284 related articles for article (PubMed ID: 20092374)
1. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
2. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
3. Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study.
Goebell E; Fiehler J; Ding XQ; Paustenbach S; Nietz S; Heese O; Kucinski T; Hagel C; Westphal M; Zeumer H
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1426-31. PubMed ID: 16908551
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Spectroscopy of Intra-axial Gliomas With Histopathological Correlation in a Tertiary Care Center of Eastern Nepal.
Tiwari S; Gyawali I
Cureus; 2024 Feb; 16(2):e54287. PubMed ID: 38496065
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
[TBL] [Abstract][Full Text] [Related]
6. Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases.
Ostojic J; Kozic D; Panjkovic M; Georgievski-Brkic B; Dragicevic D; Lovrenski A; Boban J
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674308
[No Abstract] [Full Text] [Related]
7. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
Chen AM; Gerhalter T; Dehkharghani S; Peralta R; Gajdošík M; Gajdošík M; Tordjman M; Zabludovsky J; Sheriff S; Ahn S; Babb JS; Bushnik T; Zarate A; Silver JM; Im BS; Wall SP; Madelin G; Kirov II
Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
[TBL] [Abstract][Full Text] [Related]
8. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy.
Alkan A; Sarac K; Kutlu R; Yakinci C; Sigirci A; Aslan M; Baysal T
AJNR Am J Neuroradiol; 2003 Mar; 24(3):501-6. PubMed ID: 12637304
[TBL] [Abstract][Full Text] [Related]
9. Unique magnetic resonance spectroscopy profile of intracranial meningiomas compared to gliomas: a systematic review.
De Stefano FA; Morell AA; Smith G; Warner T; Soldozy S; Elarjani T; Eichberg DG; Luther E; Komotar RJ
Acta Neurol Belg; 2023 Dec; 123(6):2077-2084. PubMed ID: 36595196
[TBL] [Abstract][Full Text] [Related]
10. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
Angelie E; Bonmartin A; Boudraa A; Gonnaud PM; Mallet JJ; Sappey-Marinier D
AJNR Am J Neuroradiol; 2001 Jan; 22(1):119-27. PubMed ID: 11158897
[TBL] [Abstract][Full Text] [Related]
11. Global brain metabolic quantification with whole-head proton MRS at 3 T.
Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Jaswal A; Gupta SK; Chhabra R; Radotra BD; Mishra AK
Nucl Med Commun; 2020 Sep; 41(9):848-857. PubMed ID: 32796472
[TBL] [Abstract][Full Text] [Related]
13. Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors.
Guzmán-De-Villoria JA; Mateos-Pérez JM; Fernández-García P; Castro E; Desco M
Cancer Imaging; 2014 Dec; 14(1):35. PubMed ID: 25608821
[TBL] [Abstract][Full Text] [Related]
14. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic utility on 1.5T and 3.0T
Qu B; Tan H; Xiao M; Liu D; Wang S; Zhang Y; Chen R; Zheng G; Yang Y; Yan G; Qu X
BMC Med Imaging; 2023 Nov; 23(1):185. PubMed ID: 37964218
[TBL] [Abstract][Full Text] [Related]
16. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
[TBL] [Abstract][Full Text] [Related]
17. Application of
Wang J; Zhou T; Liu J; Shangguan J; Liu X; Li Z; Zhou X; Ren Y; Wang C
BMC Nephrol; 2020 Jun; 21(1):225. PubMed ID: 32539705
[TBL] [Abstract][Full Text] [Related]
18. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.
Davitz MS; Wu WE; Soher BJ; Babb JS; Kirov II; Huang J; Fatterpekar G; Gonen O
Magn Reson Imaging; 2017 Jan; 35():15-19. PubMed ID: 27580518
[TBL] [Abstract][Full Text] [Related]
19. Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas.
Price SJ; Young AM; Scotton WJ; Ching J; Mohsen LA; Boonzaier NR; Lupson VC; Griffiths JR; McLean MA; Larkin TJ
J Magn Reson Imaging; 2016 Feb; 43(2):487-94. PubMed ID: 26140696
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.
Lu S; Ahn D; Johnson G; Cha S
AJNR Am J Neuroradiol; 2003 May; 24(5):937-41. PubMed ID: 12748097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
